When Aurinia Pharmaceuticals launched its first FDA-approved product, LUPKYNIS® (voclosporin), in January 2021, the organization sought to establish a modern pharmacovigilance (PV) infrastructure that could
When a global top-5 pharmaceutical company launched a groundbreaking therapy in one of its largest and most strategically important markets, the organization experienced a rapid
Managing safety data across multiple markets presents significant operational challenges, particularly when data arrives in different formats, languages, and volumes. For a top-50 holistic healthcare
As pharmacovigilance organizations manage increasing reporting volumes and more complex compliance requirements, efficient safety data intake becomes critical. A leading top-10 pharmaceutical company recognized that
The COVID-19 pandemic created unprecedented operational demands across the pharmaceutical industry. For a longstanding Qinecsa client, a top-5 pharmaceutical company, maintaining continuity in critical case
For large pharmaceutical organizations, maintaining consistent signal detection and safety surveillance processes across multiple business units can be challenging. A top-10 pharmaceutical company sought to
Building a Compliant Drug Safety Framework for Early-Phase Clinical Trials As biotech organizations advance promising therapies through clinical development, pharmacovigilance requirements become increasingly complex. Following
Scalable End-to-End Clinical Pharmacovigilance for a Resource-Constrained Biotech As clinical development programs expand, biotechnology companies often face increasing pharmacovigilance (PV) demands while operating with limited
Increasing Medical Information Call Center Compliance and Efficiency Delivering timely, compliant, and high-quality medical information is critical for pharmaceutical companies operating in a global environment.
Enabling Product Commercialization Through a Compliant Pharmacovigilance Framework A global pharmaceutical company engaged Qinecsa following a European Medicines Agency (EMA) inspection that identified several critical
